BEONE MEDICINES LTD. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BEONE MEDICINES LTD. (BEIGF) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $441.62 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-02-27
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $96.00M, a 22.80% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $103.37M, a 27.14% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-03-31 was $75.32M, a 14.90% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2022-09-30 was $78.18M, a 16.55% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $441.62M, a 20.13% increase from fiscal 2023.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $367.62M, a 21.26% increase from fiscal 2022.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $303.16M.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $183.48M, a 36.77% increase from fiscal 2019.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2024-12-31 | $441.62M 10-K · filed 2025-02-27 | |||
| 2023-12-31 | $367.62M 10-K · filed 2025-02-27 | |||
| 2023-09-30 | $96.00M 10-Q · filed 2023-11-09 | $199.38M derived: sum of 2 quarters · filed 2023-11-09 | $274.70M derived: sum of 3 quarters · filed 2023-11-09 | |
| 2023-06-30 | $103.37M 10-Q · filed 2023-11-09 | $178.69M derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2023-03-31 | $75.32M 10-Q · filed 2023-11-09 | |||
| 2022-12-31 | $303.16M 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $78.18M 10-Q · filed 2023-11-09 | $159.48M derived: sum of 2 quarters · filed 2023-11-09 | $225.04M derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $81.31M 10-Q · filed 2023-11-09 | $146.86M derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $65.56M 10-Q · filed 2023-11-09 | |||
| 2021-09-30 | $67.08M 10-Q · filed 2022-11-09 | $131.87M derived: sum of 2 quarters · filed 2022-11-09 | $177.70M derived: sum of 3 quarters · filed 2022-11-09 | |
| 2021-06-30 | $64.79M 10-Q · filed 2022-11-09 | $110.62M derived: sum of 2 quarters · filed 2022-11-09 | ||
| 2021-03-31 | $45.83M 10-Q · filed 2022-11-09 | |||
| 2020-12-31 | $183.48M 10-K · filed 2021-02-25 | |||
| 2020-09-30 | $50.30M 10-Q · filed 2021-11-04 | $95.77M derived: sum of 2 quarters · filed 2021-11-04 | $134.02M derived: sum of 3 quarters · filed 2021-11-04 | |
| 2020-06-30 | $45.47M 10-Q · filed 2021-11-04 | $83.72M derived: sum of 2 quarters · filed 2021-11-04 | ||
| 2020-03-31 | $38.26M 10-Q · filed 2021-11-04 | |||
| 2019-12-31 | $134.15M 10-K · filed 2021-02-25 | |||
| 2018-12-31 | $87.13M 10-K · filed 2021-02-25 |